Meghan E McGrady1, Gabriella A Brown2, Ahna L H Pai2. 1. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, MLC 7039, 3333 Burnet Avenue, Cincinnati, OH 45229-3026, USA; Patient and Family Wellness Center, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, MLC 7039, 3333 Burnet Avenue, Cincinnati, OH 45229-3026, USA. Electronic address: Meghan.McGrady@cchmc.org. 2. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, MLC 7039, 3333 Burnet Avenue, Cincinnati, OH 45229-3026, USA; Patient and Family Wellness Center, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, MLC 7039, 3333 Burnet Avenue, Cincinnati, OH 45229-3026, USA.
Abstract
PURPOSE: Nearly half of all adolescents and young adults (AYAs) with cancer struggle to adhere to oral chemotherapy or antibiotic prophylactic medication included in treatment protocols. The mechanisms that drive non-adherence remain unknown, leaving health care providers with few strategies to improve adherence among their patients. The purpose of this study was to use qualitative methods to investigate the mechanisms that drive the daily adherence decision-making process among AYAs with cancer. METHODS: Twelve AYAs (ages 15-31) with cancer who had a current medication regimen that included oral chemotherapy or antibiotic prophylactic medication participated in this study. Adolescents and young adults completed a semi-structured interview and a card sorting task to elucidate the themes that impact adherence decision-making. Interviews were transcribed verbatim and coded twice by two independent raters to identify key themes and develop an overarching theoretical framework. RESULTS: Adolescents and young adults with cancer described adherence decision-making as a complex, multi-dimensional process influenced by personal goals and values, knowledge, skills, and environmental and social factors. Themes were generally consistent across medication regimens but differed with age, with older AYAs discussing long-term impacts and receiving physical support from their caregivers more than younger AYAs. CONCLUSIONS: The mechanisms that drive daily adherence decision-making among AYAs with cancer are consistent with those described in empirically-supported models of adherence among adults with other chronic medical conditions. These mechanisms offer several modifiable targets for health care providers striving to improve adherence among this vulnerable population.
PURPOSE: Nearly half of all adolescents and young adults (AYAs) with cancer struggle to adhere to oral chemotherapy or antibiotic prophylactic medication included in treatment protocols. The mechanisms that drive non-adherence remain unknown, leaving health care providers with few strategies to improve adherence among their patients. The purpose of this study was to use qualitative methods to investigate the mechanisms that drive the daily adherence decision-making process among AYAs with cancer. METHODS: Twelve AYAs (ages 15-31) with cancer who had a current medication regimen that included oral chemotherapy or antibiotic prophylactic medication participated in this study. Adolescents and young adults completed a semi-structured interview and a card sorting task to elucidate the themes that impact adherence decision-making. Interviews were transcribed verbatim and coded twice by two independent raters to identify key themes and develop an overarching theoretical framework. RESULTS: Adolescents and young adults with cancer described adherence decision-making as a complex, multi-dimensional process influenced by personal goals and values, knowledge, skills, and environmental and social factors. Themes were generally consistent across medication regimens but differed with age, with older AYAs discussing long-term impacts and receiving physical support from their caregivers more than younger AYAs. CONCLUSIONS: The mechanisms that drive daily adherence decision-making among AYAs with cancer are consistent with those described in empirically-supported models of adherence among adults with other chronic medical conditions. These mechanisms offer several modifiable targets for health care providers striving to improve adherence among this vulnerable population.
Authors: K Rivet Amico; William Barta; Deborah J Konkle-Parker; Jeffrey D Fisher; Deborah H Cornman; Paul A Shuper; William A Fisher Journal: AIDS Behav Date: 2007-09-18
Authors: Kenneth K Khamly; Vicky J Thursfield; Michael Fay; Jayesh Desai; Guy C Toner; Peter F M Choong; Samuel Y K Ngan; Gerard J Powell; David M Thomas Journal: Int J Cancer Date: 2009-07-15 Impact factor: 7.396
Authors: Tim Wysocki; Michael A Harris; Lisa M Buckloh; Deborah Mertlich; Amanda Sobel Lochrie; Alexandra Taylor; Michelle Sadler; Neil H White Journal: Behav Ther Date: 2007-10-18
Authors: Yelena P Wu; David D Stenehjem; Lauri A Linder; Bin Yu; Bridget Grahmann Parsons; Ryan Mooney; Mark N Fluchel Journal: J Pediatr Oncol Nurs Date: 2017-11-30 Impact factor: 1.636
Authors: Yelena P Wu; Lauri A Linder; Patsaporn Kanokvimankul; Brynn Fowler; Bridget G Parsons; Catherine F Macpherson; Rebecca H Johnson Journal: Oncol Nurs Forum Date: 2018-01-01 Impact factor: 2.172
Authors: Alexandra M Psihogios; Lisa A Schwartz; Kylie B Ewing; Bryn Czerniecki; Leslie S Kersun; Ahna L H Pai; Janet A Deatrick; Lamia P Barakat Journal: J Adolesc Young Adult Oncol Date: 2020-05-11 Impact factor: 2.223
Authors: Alexandra M Psihogios; Mashfiqui Rabbi; Annisa Ahmed; Elise R McKelvey; Yimei Li; Jean-Philippe Laurenceau; Stephen P Hunger; Linda Fleisher; Ahna Lh Pai; Lisa A Schwartz; Susan A Murphy; Lamia P Barakat Journal: JMIR Res Protoc Date: 2021-10-22
Authors: Lori Wiener; Kimberly Canter; Kristin Long; Alexandra M Psihogios; Amanda L Thompson Journal: Psychooncology Date: 2020-10-21 Impact factor: 3.955
Authors: Kai Qi Elizabeth Peh; Yu Heng Kwan; Hendra Goh; Hasna Ramchandani; Jie Kie Phang; Zhui Ying Lim; Dionne Hui Fang Loh; Truls Østbye; Dan V Blalock; Sungwon Yoon; Hayden Barry Bosworth; Lian Leng Low; Julian Thumboo Journal: J Gen Intern Med Date: 2021-03-03 Impact factor: 5.128